84 studies found for:    Frontotemporal Dementia
Show Display Options
Rank Status Study
21 Completed
Has Results
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
Condition: Niemann-Pick Disease, Type C
Intervention: Drug: N-Acetyl Cysteine
22 Active, not recruiting Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly
Condition: Alzheimer's Disease
Interventions: Radiation: 11C-PIB PET Scan;   Radiation: FDG-PET Scan
23 Completed Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
Conditions: Alzheimer's Disease;   Frontotemporal Dementia
Interventions: Drug: florbetapir 18F;   Drug: 18F-FDG
24 Recruiting Longitudinal Study of Cognition With Niemann-Pick Disease, Type C
Condition: Niemann-Pick Disease, Type C
Intervention:
25 Unknown  Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized
Condition: Alzheimer's Disease
Intervention:
26 Recruiting Living With Frontotemporal Dementia
Condition: Adaptation
Intervention:
27 Active, not recruiting Computational Tools for Early Diagnosis of Memory Disorders
Conditions: Alzheimer Disease;   Frontotemporal Dementia;   Dementia, Vascular;   Mild Cognitive Impairment
Intervention:
28 Recruiting Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Condition: Neimann-Pick Disease
Intervention:
29 Recruiting PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
Conditions: Frontotemporal Lobar Degeneration;   Dementia
Intervention:
30 Recruiting Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Condition: Niemann-Pick Disease, Type C1
Intervention: Drug: 2-hydroxypropyl-beta-cyclodextrin
31 Completed Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Vascular Dementia;   Fronto-temporal Dementia;   Primary Progressive Aphasia;   Parkinson' Disease Dementia;   Mixed Dementia
Intervention:
32 Recruiting Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family
Conditions: Frontotemporal Dementia;   Alzheimer's Disease.
Intervention:
33 Completed P-glycoprotein Function in Brain Diseases
Conditions: Alzheimer Disease;   Parkinson Disease;   Frontotemporal Lobar Degeneration
Intervention:
34 Recruiting Social Cognition in Ageing and in Frontotemporal Lobar Degeneration
Conditions: Frontotemporal Lobar Degeneration;   Aging
Interventions: Behavioral: Cognitive assessment;   Other: Brain imaging examination MRI
35 Terminated Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Conditions: Acid Sphingomyelinase Deficiency;   Niemann-Pick Disease
Intervention: Drug: rhASM
36 Unknown  Language Treatment for Progressive Aphasia
Conditions: Primary Progressive Aphasia;   Nonfluent Progressive Aphasia;   Semantic Dementia
Intervention: Behavioral: Errorless learning
37 Enrolling by invitation A Composite MR Neuroimaging Marker for Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Frontotemporal Dementia
Intervention:
38 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
39 Recruiting Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   PLS;   Motor Neuron Disease;   Lou Gehrigs Disease;   Familial Disease;   Amyotrophic Lateral Sclerosis, Sporadic
Intervention:
40 Recruiting PiB PET Scanning in Speech and Language Based Dementias
Conditions: PPA;   Primary Progressive Aphasia;   Aphasia;   Non-fluent Aphasia;   Semantic Dementia;   Apraxia of Speech;   Primary Progressive Nonfluent Aphasia;   Progressive Aphasia
Interventions: Drug: C-11 PiB;   Drug: F-18 FDG

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years